Joint Regeneration Stack

The Joint Regeneration Stack builds upon the foundational Wolverine Stack by adding GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper complex), a naturally occurring tripeptide-copper complex that declines significantly with age. GHK-Cu is one of the most studied peptides for tissue remodeling, with over 60 published studies demonstrating its ability to stimulate collagen synthesis, attract immune cells to sites of damage, promote glycosaminoglycan production, and modulate metalloproteinase activity — all critical processes for joint cartilage maintenance and repair. BPC-157 contributes its characteristic angiogenic and growth-factor-modulating properties, creating improved blood supply to hypovascular joint tissues such as cartilage and menisci, which normally receive limited circulation. TB-500 provides systemic anti-inflammatory effects and promotes cellular migration, ensuring repair cells can reach deep joint structures. The addition of GHK-Cu specifically targets the extracellular matrix remodeling that is essential for cartilage and synovial tissue regeneration. The three-peptide synergy addresses joint degeneration from multiple angles simultaneously: BPC-157 restores vascular supply and growth factor signaling, TB-500 reduces chronic inflammation and enables cellular trafficking, and GHK-Cu directly stimulates the synthesis of collagen type II, proteoglycans, and other structural components of articular cartilage. This makes the stack particularly suitable for individuals with degenerative joint conditions, chronic tendinopathy, or those recovering from joint injuries where simple rest and anti-inflammatories have proven insufficient. The intermediate classification reflects the three-compound complexity and the need for consistent dosing across different schedules.